TacticScaleWhat Medtronic Does & How It Makes Money (MDT)
Updated October 2026 · reflects Medtronic's latest reported financials
Global medical device maker spanning heart, brain, surgery, and diabetes care. Medtronic sells implantable devices, surgical instruments, and related consumables and software to healthcare systems, physicians, and patients.
How Medtronic makes money
Medtronic sells implantable devices, surgical instruments, and related consumables and software to healthcare systems, physicians, and patients. Revenue comes from three segments: Cardiovascular, Neuroscience, and Medical Surgical. Disposables such as staplers, sensors, and pump supplies bring in repeat purchases.
What Medtronic does
Medtronic plc is one of the broadest device-based medical therapy companies. It was founded in 1949 and is headquartered in Galway, Ireland. It reports three segments. Cardiovascular covers pacemakers, defibrillators, cardiac resynchronization devices, ablation products, insertable cardiac monitors, and aortic and transcatheter valves. It also includes stent grafts, left atrial appendage exclusion, ECMO systems, coronary intervention products, and remote monitoring software. Neuroscience provides spinal implants, biologics, spinal cord stimulation and brain modulation systems, implantable drug infusion, ENT products, and the Accurian nerve ablation system. It serves spine surgeons, neurosurgeons, pain specialists, urologists, and others. Medical Surgical includes surgical stapling, vessel sealing, wound closure, electrosurgery, hernia mesh, robotic-assisted surgery, and an AI-powered surgical video and analytics platform. It also covers gastrointestinal diagnostics, patient monitoring, airway management, and diabetes products including insulin pumps, continuous glucose monitors, and sensors. The company sells worldwide to health systems, physicians, and patients. Long-lived implants and recurring surgical and diabetes consumables make up a diversified revenue base.
Products & services
- Implantable pacemakers and defibrillators
- Aortic and transcatheter heart valves
- Spinal cord stimulation and brain modulation systems
- Robotic-assisted surgery and surgical stapling devices
- Insulin pumps and continuous glucose monitoring systems
- Accurian nerve ablation system
What is Medtronic worth?
On an owner-earnings DCF, Medtronic's most-likely value is about $100 versus a recent price near $88 (13% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$54) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Boston Scientific (BSX) · Merit Medical Systems (MMSI) · Integer (ITGR) · Edwards Lifesciences (EW) · Abbott Laboratories (ABT)